Insights into a mechanism underlying resistance observed in some AMD non-responders come from a recent article by Wroblewski et al. that showed increased levels of GzmB from mast cells upon anti-VEGF treatment for cancer (tumor angiogenesis) (56). Here, GZMB is linked to neoplasm.